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Abstract
Background: Diarrhea is a leading cause of morbidity and mortality globally; yet the overall burden of diarrhea in
terms of duration and severity has not been quantified. As improvements in treatment lead to decreases in
diarrhea mortality, it is important to understand the substantial impact of diarrhea morbidity on disability among
children and adults worldwide.
Methods: We conducted a systematic review to generate estimates of duration and severity outcomes for
individuals 0-59 mos, 5-15 yrs, and ≥ 16 yrs, and for 3 severity indexes: mild, moderate, and severe.
Results: We estimate that among children under-five, 64.8% of diarrheal episodes are mild, 34.7% are moderate,
and 0.5% are severe. On average, mild episodes last 4.3 days, and severe episodes last 8.4 days and cause
dehydration in 84.6% of cases. We estimate that among older children and adults, 95% of episodes are mild; 4.95%
are moderate; and 0.05% are severe. Among individuals ≥ 16 yrs, severe episodes typically last 2.6 days and cause
dehydration in 92.8% of cases.
Conclusions: Moderate and severe episodes constitute a substantial portion of the total envelope of diarrhea
among children under-five (35.2%; about 588 million episodes). Among older children and adults, moderate and
severe episodes account for a much smaller proportion of the total envelope of diarrhea (5%), but the absolute
number of such episodes is noteworthy (about 21.5 million episodes among individuals ≥ 16 yrs). Hence, the
global burden of diarrhea consists of significant morbidity, extending beyond episodes progressing to death.
Background
Diarrhea is a leading cause of morbidity and mortality
a c r o s sa l la g eg r o u p sa n dr e g i o n so ft h ew o r l d .A m o n g
children 0-59 months of age, diarrhea is responsible for
1.236 million deaths annually and is the second leading
cause of death in this age group [1]. Though mortality
rates among older children, adolescents, and adults are
lower than those observed in children under five, diar-
rhea still poses a substantial burden accounting for
approximately 2.8 billion diarrhea episodes among older
children, adolescents, and adults [2].
Given the importance of diarrhea as one of the fore-
most causes of global morbidity and mortality, it is
essential to quantify factors, such as duration and
severity, critical to quantifying the overall burden of dis-
e a s ea t t r i b u t a b l et od i a r r h e a .C o m p r e h e n s i v ee s t i m a t e s
of diarrheal duration and severity will allow for the
more accurate assignment of disability adjusted life
years (DALYs) in terms of years lost to disability due to
diarrheal illness. While various studies conducted
throughout the world report on the duration and sever-
ity of diarrhea, comprehensive estimates do not exist in
the literature. Furthermore, there is a lack of consistency
in methods for defining severe, moderate, and mild diar-
rheal episodes despite the existence of severity scales,
such as the Hjelt, Vesikari, and Clark scoring systems,
which assign an overall degree of severity based on the
sum presentation of symptoms [3-5]. We therefore con-
ducted a systematic literature review with the goal of
consolidating available data on the duration and severity
of diarrhea and describing the overall burden of * Correspondence: llambert@jhsph.edu
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Methods
Search strategy and selection criteria
We systematically reviewed all literature published from
1990 to 2010 to identify studies reporting measures of
diarrhea duration and severity in children and adults.
From May 20-27, 2010, we searched in Pubmed using
combinations of MeSH search terms: diarrhea, gastroen-
teritis, duration, persistence, severity, infant, child, teen-
age, and adult.
We initially screened all unique publications for elig-
ibility based on the relevancy of title and abstract; we
then screened the full manuscripts for inclusion and
exclusion criteria. We included randomized controlled
trials (RCTs), cohort, and observational studies pub-
lished in any language and conducted in any country.
Included studies contained data on diarrhea duration
and/or severity in children and/or adults. We excluded
studies with unclear methodology and diarrhea recall
beyond 2 weeks. We accepted studies defining diarrhea
as the passage of ≥ 3 watery stools in a 24-hour period;
we also considered mother’s report of a change in usual
stool consistency or frequency for infants ≤ 11 mo of
age, and the diagnosis of diarrhea by a physician or
nurse as valid case definitions. We excluded studies
describing diarrhea deaths alone since duration and
severity outcomes of episodes resulting in death are not
generalizable to all diarrhea episodes. We also excluded
reports of nosocomial outbreaks, diarrhea due to known
chronic or non-infectious illness, and studies that lim-
ited inclusion to one etiologic agent. For analytical pur-
poses, we did not include studies that combined
outcomes across child/adult age categories or inpatient/
outpatient status. Furthermore, for duration outcomes,
we included studies on the natural course of diarrhea
episodes and excluded those reporting on acute or per-
sistent episodes alone.
Data abstraction
We abstracted measures of diarrhea duration and severity
for all ages; for presentation purposes we grouped these
data into 3 distinct age categories: 0-59 mos, 5-15 yrs,
and ≥ 16 years of age. For studies stratifying outcomes by
treatment or HIV-status, we only abstracted data on pla-
cebo and HIV-negative individuals, respectively.
We abstracted three outcomes describing diarrhea
duration: mean or median duration–reported as the
number of days per episode of diarrhea, and the propor-
tion of total diarrheal episodes that became persistent (≥
14 or ≥ 15 days). If the proportion of persistent cases
was skewed due to an intentional sampling bias or
matching, we did not include the study for this
outcome. To ensure capture of the full length of diar-
rheal episodes, we also excluded studies solely reporting
the duration of diarrheal episodes at baseline.
Multiple outcomes were reported as measures of
severity. We abstracted the proportion of individuals
suffering from diarrhea with mild, moderate, severe, or
any dehydration; vomiting; and bloody stools. We classi-
fied necessitating ORS or intravenous fluids as any
dehydration. For studies assessing dehydration by both
physician perception and WHO classification for dehy-
dration, we utilized the latter. Likewise, if possible, we
abstracted outcomes assessed by physicians or trained
health workers in place of those estimated by mothers
or caregivers. Additional severity outcomes included the
mean stool volume (g/kg/day) and mean stool frequency
(stools/day). We also abstracted the proportion with low
(< 40 g/kg/day), medium (40-70 g/kg/day), and high (>
70 g/kg/day) stool volume. For stool frequency, we
abstracted the proportion low (1-5 stools/day), medium
(6-9 stools/day), and high (≥ 10 stools/day), as well as
the proportion with > 5 stools/day and > 3 stools/day.
We did not find any studies able to quantify the pro-
portion of episodes that remain mild/moderate or that
progress to severe. We therefore used care-seeking
behavior among caregivers of children < 5 years of age
as a proxy for diarrhea severity in this age group. We
abstracted care-seeking behavior from the Demographic
Health Surveys (DHS) [6]. The DHS reports the number
of children ≤ 35 months of age with diarrhea in the two
weeks preceding the survey for whom care was sought,
as well as the number who were not taken to a health
provider.
Data analysis
We used STATA 10.1 to generate combined estimates
and 95% confidence intervals for all duration and severity
outcomes [7]. To ensure that confidence intervals were
lower bound by zero for all outcomes and upper bound
by one for proportions, we fit a logistic regression model
to data reported as proportions and a Poisson regression
model to continuous outcomes. All outcomes were
weighted by sample size, which consisted of the total
number of episodes. For study designs assessing only one
episode per individual, the number of children or adults
with diarrhea was considered the total number of epi-
sodes. We used the reported diarrheal incidence (number
of episodes per child-year) to estimate the sample size for
studies evaluating multiple episodes per child without
reporting the total number of episodes. We conducted
separate analyses for each study type–community, hospi-
tal-based inpatient and hospital-based outpatient.
Using the DHS data, we calculated region-specific
averages for diarrhea care-seeking. We also calculated
the median global estimate of diarrhea care-seeking
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our model describing the total envelope of diarrhea
among children under five. Mild cases were defined as
those for which no care was sought, and moderate cases
were defined as those for which care was sought
through a health provider. We assumed that mild and
moderate episodes were best described by the duration
and severity outcomes derived from community-based
studies and hospital outpatient studies, respectively. We
used the proportion of outpatient cases presenting with
severe dehydration to determine the percentage of mod-
erate cases which progress to severe. Duration and
severity outcomes derived from hospital inpatient stu-
dies were assumed to best describe severe cases. Table 1
summarizes the algorithms used to determine the pro-
portion of mild, moderate and severe cases occurring
among children 0-59 mos of age; Table 1 also lists the
source of duration and severity outcomes assumed to
best describe each diarrhea category.
We also designed a model to describe the total envel-
ope of diarrhea among individuals ≥ 16 years of age. We
assumed that mild cases were comprised of cases occur-
ring in the community without dehydration, and moder-
ate cases were comprised of the proportion of
community cases with any dehydration. In keeping with
the assumptions made for the model describing the total
envelope of diarrhea among children under-five, we
used the proportion of outpatient cases presenting with
severe dehydration to determine the percentage of mod-
erate cases progressing to severe. We also assumed that
community, hospital outpatient, and hospital inpatient
studies best described the duration and severity profiles
of mild, moderate, and severe cases, respectively (See
Table 1).
Results
Systematic literature review
The systematic literature search yielded 5708 titles for
children (Figure 1), of which we identified 41 and 27
studies for inclusion in the analysis of duration [8-48]
and severity [8,9,16,19,21,22,25,26,36,39,43,45,49-63],
respectively. All included studies reported data on chil-
dren 0-59 months of age. One duration study also
reported outcomes on children 5-15 years of age [24];
no included studies reported data on severity outcomes
among older children. Only one study was conducted in
a high income country [48]. Of the 8049 titles identified
for adults (Figure 1), we included four in the duration
analysis [24,64-66], and six in the severity analysis
[53,64-68]. All but two studies reported data from low-
and middle-income countries (LMICs) [65,66]. Across
analyses, we included 61 unique studies with study loca-
tions spanning across six WHO geographic regions (Fig-
ure 2).
Duration of diarrheal episodes
Among children 0-59 months of age, the weighted mean
duration was 4.3 days among cases assessed in the com-
munity and 8.4 days among hospital inpatients in
LMICs (Table 2). The mean and median duration
reported by the included study conducted in a high-
income country were 2.2 days and 1 day, respectively.
The sole study conducted among children 5-15 years
of age reported a mean duration of 2.7 days for episodes
assessed in the community (Table 2). The reported
mean duration of episodes among adults ≥ 16 years of
age was 3 days in the community and 2.6 days among
hospital outpatients in LMICs (Table 2); in high-income
countries, the mean duration of diarrhea was 2.6 days in
the community and 4.6 days among outpatients.
Severity of diarrheal illness
Any dehydration was the outcome most frequently cited
as a measure of diarrhea severity among children under
five. The weighted mean proportion of episodes categor-
ized with any dehydration was 7.3% for episodes
assessed in the community, 84.6% among hospital inpa-
tients and 51.4% among hospital outpatients (Table 3).
Table 1 Algorithms used to determine the total envelope of childhood and adult diarrhea
Envelope of
Diarrhea
Severity Algorithm (Data Source)
1 Source of Duration & Severity
Outcomes
Childhood
Diarrhea
Mild Proportion not seeking care (DHS) Community-based studies
Moderate Proportion seeking care (DHS)
Proportion outpatients without severe dehydration (MA)
Hospital outpatient studies
Severe Proportion seeking care (DHS)
Proportion outpatients with severe dehydration (MA)
Hospital inpatient studies
Adult Diarrhea Mild Proportion community-based cases without dehydration (MA) Community-based studies
Moderate Proportion community-based cases with any dehydration (MA) Hospital outpatient studies
Severe Proportion community-based cases with any dehydration Proportion outpatients
with severe dehydration (MA)
Hospital inpatient studies
1Data Sources: DHS Global average based on DHS report of diarrhea careseeking among children ≤ 35 mos; MA meta-analyses reported here
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measure of diarrhea severity among individuals ≥ 16
years of age (Table 4). The weighted mean proportion
of episodes presenting with any dehydration was 92.8%
for hospital inpatient studies, 30.1% for hospital outpati-
ent studies, and 5.0% for community studies.
Diarrhea care-seeking practices
The DHS-based regional average and global median
proportions of care-seeking for diarrhea among children
under three years are presented in Table 5. Care-seeking
for diarrhea was highest in North Africa/West Asia/Eur-
ope (41.0%) and lowest in South/Southeast Asia (31.0%)
and West/Middle Africa (26.9%). The median global
estimate of care-seeking for diarrhea among children
under-five was 35.2%
Estimating the total envelope of diarrhea
Figure 3 describes the total envelope of diarrhea mor-
bidity among children 0-59 mos of age. Using care-
seeking as a proxy for quantifying the proportion of
diarrhea episodes which might be considered “mild”,w e
estimate that 64.8% of episodes are mild and the
remaining 35.2% of cases are moderate. Of these moder-
ate cases, 1.4% will become severe (i.e. 0.5% of all cases).
Using the data from community-based studies we esti-
mate that mild cases last for 4.3 days. We estimate that
15.4% of moderate cases become persistent and 51.4%
involve some dehydration. For severe cases, we applied
the estimates derived from inpatient studies and thus
assumed that severe cases endure 8.4 days with 84.6%
resulting in dehydration. Since included outpatient stu-
dies did not report mean duration, we estimated the
mean duration of moderate cases by averaging that of
mild and severe cases; thus, moderate cases last approxi-
mately 6.4 days.
Figure 4 describes the total envelope of diarrhea bur-
den among individuals ≥ 16 years of age. Since severe
dehydration was not reported by any of the outpatient
studies included in this review, we determined the
5708 titles identified  
for possible inclusion in analysis of  
duration and severity among children 
405 abstracts identified 
175 full papers screened 
41 papers included  in 
duration analysis
3,4 
Abstracts Screened 
57,084 titles identified using  
combinations of Mesh search terms for diarrhea 
Titles Screened 
4 papers included in 
duration analysis
7 
284 abstracts identified 
57 full papers screened 
27 papers included in 
severity analysis
5,6 
6 papers included in 
severity analysis
8 
8049 titles identified  
for possible inclusion in analysis of  
duration and severity among adults 
119 papers excluded based 
on exclusion criteria
1 
50 papers excluded based 
on exclusion criteria
2 
Figure 1 Flow chart diagram of the systematic review process.
1Main reasons for exclusion: report of one etiologic agent (n = 30);
inadequate definition of diarrhea (n = 15); overlapping age categories (n = 17); no outcome of interest (n = 12); diarrhea recall beyond 2 weeks
(n = 11); unclear/problematic methodology (n = 11); data in unusable form (n = 6); full episodes not followed (n = 6); not representative of
general population (n = 4); combined data on hospital inpatients & outpatients (n = 7).
2Main reasons for exclusion: report of one etiologic
agent (n = 20); overlapping age categories (n = 12); not representative of general population (n = 5); report of nosocomial infection (n = 3);
unclear/problematic methodology (n = 3); diarrhea recall beyond 2 weeks (n = 4); inadequate definition of diarrhea (n = 1); no outcome of
interest (n = 1); combined data on hospital inpatients & outpatients (n = 1).
3All studies reported data on children 0-59 mos of age; one study
reported data on children 5-15 yrs of age.
4Study design: cohort (n = 27); RCT (n = 10); case-control (n = 4). Study location: community-based (n
= 34); hospital-based (n = 7).
5All studies reported data on children 0-59 mos of age, only.
6Study design: cohort (n = 15); RCT (n = 5); case-
control (n = 7). Study location: community-based (n = 10); hospital-based (n = 17).
7Study design: cohort (n = 2); RCT (n = 2). Study location:
community-based (n = 2); hospital-based (n = 2).
8Study design: cohort (n = 4); RCT (n = 2). Study location: community-based (n = 2); hospital-
based (n = 4).
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Page 4 of 11Figure 2 Location of studies reporting diarrhea duration and severity outcomes for children and adults. Locations of 61 unique studies;
one study represented at 3 different locations.
Table 2 Estimates of diarrhea duration by age and country income-status
Duration Outcome Study Design Study Sites
1
N
Combined Estimate
% (95% CI)
Low- and middle-income countries
0-59 mos
Weighted Mean
2 Community 29 4.3 (4.3-4.4)
Hospital - Inpatient 2 8.4 (8.1-8.8)
Weighted Median
2 Community 8 3.1 (3.0-3.2)
Hospital - Inpatient 1 2.0 (-)
Weighted Proportion Persistent
3 Community 12 4.9 (4.6-5.2)
Hospital - Inpatient 4 11.1 (9.3-12.9)
Hospital - Outpatient 1 15.4 (-)
5-15 yrs
Mean Community 1 2.7 (-)
≥ 16 yrs
Mean Community 1 3.0 (-)
Hospital - Inpatient 1 2.6 (-)
High-income countries
0-59 mos
Mean Community 1 2.2 (-)
Median Community 1 1.0 (-)
≥ 16 yrs
Mean Community 1 2.6 (-)
Hospital - Outpatient 1 4.6 (3.6-5.2)
1Individual studies may contribute more than one study site (N) to each estimate
2Estimates for ≥ 2 study sites generated by Poisson regression model weighted
by sample size
3Estimates for ≥ 2 study sites generated by logistic regression model weighted by sample size
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among individuals ≥ 16 years of age by rounding down
the proportion derived for children (1.4%); thus, of the
5% of cases characterized as moderate, 1% (i.e. 0.05% of
all cases) evolve into severe episodes. Approximately 5%
of mild, 30.1% of moderate and 92.8% of severe cases
result in dehydration. Although we aimed to character-
ize the duration of mild, moderate, and severe cases
using the averages reported by community, hospital
inpatient, and hospital outpatient studies, respectively,
mean duration was only reported by one included com-
munity study (3.0 days) and one included hospital inpa-
tient study (2.6 days). We therefore averaged the
duration reported by the two studies and applied this
figure (2.8 days) to the duration of mild, moderate, and
severe cases.
Discussion
This systematic review is the first to describe the overall
duration and severity of diarrhea among children and
adults. To estimate the annual number of diarrhea epi-
sodes among children under-five by region, we applied
the regional age-adjusted incidences of diarrhea among
children 0-59 mos of age to the regional populations of
children in that age group. The total number of diarrhea
episodes, as well as the breakdown of mild, moderate,
and severe episodes in each region, is presented in
Table 6. By aggregating the regional numbers, we
Table 3 Measures of severity of diarrhea among children 0-59 mos of age by study type
Study Sites
1
N
Weighted Mean
2
% (95% CI)
Community
Dehydration Any 6 7.3 (6.6-8.0)
Severe 1 10.9 (-)
Vomiting 10 18.1 (17.4-18.7)
Bloody Stool 9 8.7 (8.2-9.2)
Stool Frequency
3 Frequency > 5 stools/day 3 13.4 (12.5-14.2)
Frequency > 3 stools/day 2 57.5 (54.4-60.5)
Mean Stool Frequency (stools/day) 3 4.99 (4.80-5.18)
Hospital Outpatient
Dehydration Any 3 51.4 (49.1-53.8)
Mild 1 32.8 (-)
Moderate 4 45.1 (43.5-46.7)
Severe 2 1.4 (0.7-2.1)
Vomiting 2 55.7 (52.8-58.5)
Stool Frequency
3 Low 1 63.4 (-)
Medium 1 22.7 (-)
High 1 14.0 (-)
Frequency > 5 stools/day 1 55.1 (-)
Frequency > 3 stools/day 3 84.4 (83.0-85.7)
Hospital Inpatient
Dehydration Any 7 84.6 (83.1-86.1)
Mild 5 66.7 (63.4-70.0)
Moderate 6 18.6 (16.2-20.9)
Severe 10 8.1 (7.6-8.6)
Vomiting 2 58.3 (54.3-62.2)
Bloody Stool 1 16.2 (-)
Stool Frequency
3 High 1 53.6 (-)
Frequency > 5 stools/day 1 90.0 (-)
Stool Volume Mean Stool Volume (kg/g/day) 1 52.6 (-)
1Individual studies (n = 27) may contribute more than one study site (N) to each estimate
2Estimates for ≥ 2 study sites generated by logistic regression model
weighted by sample size; mean stool frequency generated by Poisson regression model weighted by sample size
3Low defined as 1-5 stools/day; medium as 6-9
stools/day; and high as ≥ 10 stools/day
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occurring among children under-five globally per year
1.08 billion (64.8%) are mild; 580 million are moderate
(34.7%); and 8 million (0.5%) are severe. By region, the
burden of diarrhea is greatest in Africa and Asia; still,
Table 7 illustrates that episodes occurring in Africa tend
to be more serious in duration and severity outcomes.
The total envelope of diarrhea cases among individuals
≥ 16 years of age is comprised of approximately 430
million annual episodes of diarrhea [2]. We estimate
that approximately 408.5 million episodes are mild
(95%); 21.3 million are moderate (4.95%); and 0.2 mil-
lion are severe (0.05%).
The dearth of studies reporting outcomes for children
5-15 years of age inhibits our ability to directly estimate
the burden of diarrhea on this age group. However, a
comparison of the mean duration of community-based
cases seems to suggest that diarrhea outcomes among
children aged 5-15 yrs are more similar to individuals ≥
16 than to children under-five( T a b l e2 ) .A c c o r d i n g l y ,
we applied the breakdown of mild, moderate, and severe
cases estimated for individuals ≥ 16 to the total number
of incident cases among children 5-15 years of age. We
estimate that of the 200 million diarrheal episodes that
occur per year among children 5-15 years of age [2],
190 million are mild (95%); 9.9 million are moderate
(4.95%); and 0.1 million are severe (0.05%).
Our review is limited in that we cannot extrapolate
our findings onto the duration and severity of diarrhea
episodes occurring among HIV-infected individuals.
Table 4 Measures of severity of diarrhea among individuals ≥ 16 yrs of age by country income-status
Study Sites
1
N
Weighted Mean
2
% (95% CI)
Low- and middle-income countries
Community
Dehydration Any 1 5.0 (-)
Vomiting 1 24.9 (-)
Hospital Outpatient
Dehydration Any 1 30.1 (-)
Vomiting 1 43.3 (-)
Bloody Stool 1 10.0 (-)
Stool Frequency Mean Stool Frequency (stools/day) 1 8.1 (-)
Hospital Inpatient
Dehydration Any 2 92.8 (90.1-95.5)
Mild 1 0 (-)
Moderate 1 72.7 (-)
Severe 2 40.3 (35.2-45.5)
Vomiting 1 83.0 (-)
High-income countries
Community
Vomiting 1 75.0 (-)
Hospital Outpatient
Vomiting 1 25.9 (-)
1Individual studies (n = 4) may contribute more than one study site (N) to each estimate
2Estimates for ≥ 2 study sites generated by logistic regression model
weighted by sample size
Table 5 Global care-seeking practices for diarrhea
episodes among children ≤ 36 mos of age in low- and
middle-income countries
Region Diarrhea Care-seeking (%)
West/Middle Africa* 26.9
South/East Africa** 39.1
North Africa/West Asia/Europe
^ 41.0
Central Asia
^^ 35.6
South/Southeast Asia
† 31.0
Latin America/Caribbean
†† 34.8
Global Median 35.2
DHS[6] data sources: * Benin 2001, Burkina Faso 1998-99, Cameroon 1998,
Chad 1996-97, Cote d’Ivoire 1998-99, Gabon 2000, Ghana 1998, Guinea 1999,
Mali 2001, Mauritania 2000-01, Niger 1998, Nigeria 1999, Senegal 1997, Togo
1998. ** Comoros 1996, Eritrea 2002, Ethiopia 2000, Kenya 1998, Madagascar
1997, Malawi 2000, Mozambique 1997, Namibia 2000, Rwanda 2000, South
Africa 19998, Tanzania 1999, Uganda 2000-01, Zambia 2001-02, Zimbabwe
1999.
^ Armenia 2000, Egypt 2000, Jordan 2002, Turkey 1998, Yemen 1997.
^^
Kazakhstan 1999, Kyrgz Rep. 1997, Turkmenistan 2000, Uzbekistan 1996.
†
Bangladesh 1999-00, Cambodia 2000, India 1998-99, Indonesia 1997, Nepal
2000, Philippines 1998, Vietnam 1997.
†† Bolivia 1998, Brazil 1996, Colombia
2000, Dominican Rep. 2002, Guatemala 1998-99, Haiti 2000, Nicaragua 2001,
Peru 2000.
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between individuals of discrepant HIV status has shown
that HIV increases susceptibility to infectious diseases,
including diarrhea. Of the studies we identified, one
excluded study observed that in addition to increased
diarrhea incidence, HIV-infected children suffered
higher duration and a larger proportion of persistent
episodes as compared to uninfected children [69].
Moreover, the same study reported increased diarrhea-
related mortality among HIV-infected children.
The proportion of moderate/severe episodes among
children under-five, which was estimated using the pro-
portion of episodes for which care was sought, is likely
underestimated since appropriate care is sought in less
than 30-50% of cases in resource poor settings [70].
Given that facility care is under-utilized, moderate/
ENVELOPE OF CHILDHOOD DIARRHEA 
 
MILD CASES* 
64.8% 
 
Mean duration: 4.3 d 
Persistent: 4.9% 
Any dehydration: 7.3% 
 
MODERATE CASES** 
34.7% 
 
Mean duration: 6.4 d 
Persistent: 15.4% 
Any dehydration: 51.4% 
* Mild cases defined as the proportion not seeking care according to DHS report of the average proportion  of children 35 mos with diarrhea 
for whom care was not sought in the 2 weeks prior to survey. Duration & severity outcomes described by community-based studies. 
** Moderate cases defined as the proportion seeking care according to DHS report of the average proportion  of children 35 mos with  
diarrhea for whom care was sought in the 2 weeks prior to survey. Any dehydration and proportion persistent described by hospital outpatient 
studies; mean duration estimated by averaging mean duration of mild and severe cases. 
^ Severe cases defined as the proportion of moderate cases with severe dehydration (1.4%). Duration & severity outcomes described by  
hospital inpatient studies.  
 
SEVERE CASES^ 
0.5%  
 
Mean duration: 8.4 d 
Persistent: 11.1% 
Any dehydration: 84.6% 
Figure 3 Model of the duration and severity of diarrhea among children 0-59 mos of age.
ENVELOPE OF ADULT DIARRHEA 
 
MILD CASES* 
95.0% 
 
Mean duration: 2.8 d 
Any dehydration: 5.0% 
 
MODERATE CASES** 
4.95% 
 
Mean duration: 2.8 d 
Any dehydration: 30.1% 
* Mild cases defined as the proportion of community-based cases without dehydration. Dehydration described by community studies; 
mean duration estimated by the average across included studies. 
** Moderate cases defined as the proportion of community-based cases with any dehydration. Dehydration described by hospital outpa-
tient studies; mean duration estimated by the average across included studies. 
^ Severe cases defined as 1% of moderate cases. Dehydration described by hospital inpatient studies; mean duration estimated by the 
average across included studies. 
 
SEVERE CASES^ 
0.05% of moderate cases 
 
Mean duration: 2.8 d 
Any dehydration: 92.8% 
Figure 4 Model of the duration and severity of diarrhea among individuals ≥ 16 yrs of age.
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Page 8 of 11severe episodes among children under-five are also
assessed in the community; thus, the duration and
severity outcomes derived from community-based stu-
dies may not accurately describe mild episodes that do
not require facility level care. However, the increasing
gravity of duration and severity outcomes across com-
munity-based, hospital-inpatient, and hospital-outpatient
studies, respectively, suggests that these estimates are
plausible and although biased, they represent the best
summary of available data.
Conclusions
In this review we classified the total envelope of diar-
rheal episodes among individuals 0-59 mos, 5-15 years,
and ≥ 16 years of age according to diarrhea duration
and severity. This information is essential to accurately
calculate the age-specific burden of disease and the
appropriate allocation of DALYs. Given that the global
burden of diarrhea consists of large numbers of episodes
beyond those progressing to death, the estimated break-
down of mild, moderate, and severe episodes is
increasingly important for informing policy decisions on
global health. As programs increasingly scale-up and
improve diarrhea treatment, especially among children
under-five, estimates of diarrhea morbidity should be
used to determine the most effective distribution of
funds for interventions focused on diarrhea.
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